SPONTANEOUS PULSATILITY AND PHARMACOKINETICS OF GROWTH-HORMONE IN LIVER CIRRHOTIC-PATIENTS

Citation
Y. Baruch et al., SPONTANEOUS PULSATILITY AND PHARMACOKINETICS OF GROWTH-HORMONE IN LIVER CIRRHOTIC-PATIENTS, Journal of hepatology, 29(4), 1998, pp. 559-564
Citations number
32
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
01688278
Volume
29
Issue
4
Year of publication
1998
Pages
559 - 564
Database
ISI
SICI code
0168-8278(1998)29:4<559:SPAPOG>2.0.ZU;2-F
Abstract
Background/Aims: Liver cirrhosis is characterized by high serum growth hormone levels and low serum insulin-like growth factor I and growth hormone-binding protein levels, The present study was designed to char acterize the serum profile of growth hormone and growth hormone pharma cokinetics in postnecrotic liver cirrhosis, correlating it with liver function and nutritional states. Methods: Fifteen patients were groupe d by the Child-Pugh score (group 1, score of 5 to 8; group 2, score of 9 to 12). Five healthy subjects served as controls. Nutritional statu s was assessed by the creatinine-height index. Baseline growth hormone , insulin-like growth factor, and growth hormone binding protein were measured, and growth hormone pharmacokinetics was followed for 48 h af ter administration of subcutaneous recombinant human growth hormone (0 .06 mg/kg).Results: Trough serum growth hormone (mu g/l) was higher in both patient groups (5.3+/-3.6) than in controls (1.0+/-0.3; p<0.01). More pulses were recorded in cirrhotic patients and mean pulse amplit ude (mu g/l) was higher in cirrhotic patients than in controls (p<0.01 ). After subcutaneous recombinant human growth hormone injection, maxi mal growth hormone was higher in cirrhotic patients and the area under the curve over 24 h was greater (626+/-120) than in controls (330+/-5 4; p<0.01). Single regression analysis showed a weak correlation of bo th the Child-Pugh score and the creatinine-height index with the pharm acokinetic parameters. Conclusions: Due to decreased growth hormone cl earance, patients with liver cirrhosis have increased trough and peak serum growth hormone levels, as well as lower serum growth hormone bin ding protein and insulin-like growth factor. Recombinant human growth hormone pharmacokinetics are typical of a high hepatic extraction subs tance administered to patients with liver disease and portal hypertens ion, and this may be relevant to the further use of growth hormone the rapy.